14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INCY
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Incyte Corporation stock price down 1.08% on Thursday
(Updated on Apr 25, 2024)

Sell candidate since Apr 19, 2024 Loss -2.23% PDF

The Incyte Corporation stock price fell by -1.08% on the last day (Thursday, 25th Apr 2024) from $51.74 to $51.18. During the last trading day the stock fluctuated 2.96% from a day low at $50.36 to a day high of $51.85. The price has fallen in 8 of the last 10 days and is down by -6.81% for this period. Volume has increased on the last day by 302 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $89.62 million.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $50.94 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -11.57% during the next 3 months and, with a 90% probability hold a price between $45.04 and $49.64 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INCY Signals & Forecast

There are few to no technical positive signals at the moment. The Incyte Corporation stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $52.05 and $55.85. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -16.10%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Incyte Corporation stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.49 between high and low, or 2.96%. For the last week, the stock has had daily average volatility of 1.85%.

Incyte Corporation is oversold on RSI14 (9). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INCY) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Incyte Corporation to open at $51.13, and during the day (based on 14 day Average True Range), to move between $50.09 and $52.27, which gives a possible trading interval of +/-$1.09 (+/-2.13%) up or down from last closing price. If Incyte Corporation takes out the full calculated possible swing range there will be an estimated 4.26% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $57.34, some $6.16 (12.04%) from the current price of $51.18, our system finds the risk reward not very attractive.

Earnings coming up

Incyte Corporation will release earnings BMO on Tuesday, April 30, 2024.The consensus among the analysts for the expected earnings (EPS) is $0.87. We will update the financials statements for Incyte Corporation, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 5.90% in the first trading day after earnings release.

Is Incyte Corporation stock A Buy?

Incyte Corporation holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.408 Sell Candidate Unchanged

Predicted Opening Price for Incyte Corporation of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$51.13 ( 0.0977%) $51.18

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INCY

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 52.62 2.81 %
R2 52.05 1.70 %
R1 51.70 1.01 %
Current price: 51.18
Support S1 50.56 -1.21 %
S2 50.21 -1.90 %
S3 49.64 -3.01 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 59.34 15.94 %
R2 58.37 14.05 %
R1 57.34 12.04 %
Current price 51.18
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Incyte Corporation Stock and on which exchange is it traded?
The symbol for Incyte Corporation is INCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Incyte Corporation Stock?
Incyte Corporation holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Incyte Corporation Stock?
Incyte Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Incyte Corporation Stock.

What's the current price of Incyte Corporation Stock?
As of the end of day on the Apr 25, 2024, the price of an Incyte Corporation (INCY) share was $51.18.

What is the 52-week high and low for Incyte Corporation Stock?
The 52-week high for Incyte Corporation Stock is $75.74 and the 52-week low is $50.27.

What is the market capitalization of Incyte Corporation Stock?
As of the Apr 25, 2024, the market capitalization of Incyte Corporation is 11.491B.

When is the next earnings date for Incyte Corporation?
The upcoming earnings date for Incyte Corporation is Apr 30, 2024.
Click to get the best stock tips daily for free!

About Incyte Corporation

Incyte Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr... INCY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT